Outcomes research can play a key role in the drug development process. At DRG Abacus, we have a dedicated Clinical Outcomes Assessment (COA) team whose members have extensive methodological and commercial experience.
The COA team have expertise in the development and validation of new and existing patient-reported outcomes (PROs) and other COAs used to assess important patient outcomes including symptoms, functioning, health-related quality of life (HRQoL), and treatment experience.
Our specialists are supported by a multidisciplinary team of medical writers, health economists, systematic reviewers and strategic advisors. Together, these experts provide integrated health economics and outcomes research (HEOR) and market access solutions across the product life-cycle.